| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |